Healthcare - Biotechnology - NASDAQ - US
$ 8.83
10.1 %
$ 408 M
Market Cap
-3.94
P/E
Price Target
Average
453.51%
Revenue Forecast
Estimate
46.71%
EBIT
Estimate
3.96%
Net Income
Estimate
--8.46%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
4D Molecular Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for FDMT of $48.9 , with forecasts ranging from a low of $36 to a high of $70 .
FDMT Lowest Price Target
Wall Street Target
36 USD
307.70%
FDMT Average Price Target
Wall Street Target
48.9 USD
453.51%
FDMT Highest Price Target
Wall Street Target
70 USD
692.75%
REVENUE FORECAST
Revenue Forecast Chart FDMT
EBIT FORECAST
EBIT Forecast Chart FDMT
NET INCOME FORECAST
Net Income Chart FDMT